Your browser doesn't support javascript.
loading
Study of fingolimod, nitric oxide inhibitor, and P-glycoprotein inhibitor in modulating the P-glycoprotein expression via an endothelin-sphingolipid pathway in an animal model of pharmacoresistant epilepsy.
Garg, Nitika; Joshi, Rupa; Bhatia, Alka; Bansal, Seema; Chakrabarti, Amitava; Prakash, Ajay; Saikia, Biman; Modi, Manish; Medhi, Bikash.
Afiliación
  • Garg N; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, Haryana, India.
  • Joshi R; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh; Department of Pharmacology, MM Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be university), Mullana, Ambala, Haryana, India.
  • Bhatia A; Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, Haryana, India.
  • Bansal S; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh; Department of Pharmacology, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be university), Mullana, Ambala, Haryana, India.
  • Chakrabarti A; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, Haryana, India.
  • Prakash A; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, Haryana, India.
  • Saikia B; Department of Immunopathology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, Haryana, India.
  • Modi M; Department of Neurology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, Haryana, India.
  • Medhi B; Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, Haryana, India.
Indian J Pharmacol ; 55(5): 307-314, 2023.
Article en En | MEDLINE | ID: mdl-37929409

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Epilepsia Refractaria / Clorhidrato de Fingolimod Idioma: En Revista: Indian J Pharmacol Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Epilepsia Refractaria / Clorhidrato de Fingolimod Idioma: En Revista: Indian J Pharmacol Año: 2023 Tipo del documento: Article